Market Access - Pharmaphorum

Trending

in News
Teva slumps after Express Scripts funds migraine rivals in US
October 18, 2018 Share
X
Teva slumps after Express Scripts funds migraine rivals in US
https://pharmaphorum.com/news/teva-slumps-after-express-scripts-funds-migraine-rivals-in-us/
in News
US blood pressure drug price doubles following shortages
October 17, 2018 Share
X
US blood pressure drug price doubles following shortages
https://pharmaphorum.com/news/us-blood-pressure-drug-price-doubles-following-shortages/

Latest News

Samsung Bioepis’ Humira biosimilar launches in EU

Samsung Bioepis’ Humira biosimilar launches in EU

Samsung Bioepis has become the latest biosimilars company to confirm it has launched a cheaper near-copy of AbbVie’s

X

Samsung Bioepis’ Humira biosimilar launches in EU

https://pharmaphorum.com/news/samsung-bioepis-humira-biosimilar-launches-in-eu/

Billions up for grabs as EU patent on AbbVie’s Humira expires

Billions up for grabs as EU patent on AbbVie’s Humira expires

The patent for Humira, the world’s bestselling drug, expires in Europe today – opening the door for a

X

Billions up for grabs as EU patent on AbbVie’s Humira expires

https://pharmaphorum.com/news/billions-up-for-grabs-as-eu-patent-abbvies-humira-expires/

Sandoz free to launch Humira biosimilar following AbbVie deal

Sandoz free to launch Humira biosimilar following AbbVie deal

Novartis’ generics and biosimilars arm, Sandoz, has confirmed it is to launch its biosimilar of AbbVie’s Humira (adalimumab)

X

Sandoz free to launch Humira biosimilar following AbbVie deal

https://pharmaphorum.com/news/sandoz-free-to-launch-humira-biosimilar-following-abbvie-deal/

Views & analysis

Balancing expectations: An unmet need in the orphan disease arena

Balancing expectations: An unmet need in the orphan disease arena

There are between 6000 and 8000 rare diseases in the world, and one in ten people in Europe

X

Balancing expectations: An unmet need in the orphan disease arena

https://pharmaphorum.com/views-analysis-market-access/balancing-expectations-rare-disease-arena/

Collaboration can ensure access to life-changing innovation

Collaboration can ensure access to life-changing innovation

As a pioneering risk sharing scheme has shown, new medications can be the catalyst for a whole new

X

Collaboration can ensure access to life-changing innovation

https://pharmaphorum.com/views-analysis-market-access/access-life-changing-innovation-risk-sharing-scheme/

A payer’s perspective on value-based contracting (VBC)

A payer’s perspective on value-based contracting (VBC)

What payer wouldn’t want to ensure that they pay for value when buying drugs? If the emerging trend

X

A payer’s perspective on value-based contracting (VBC)

https://pharmaphorum.com/views-analysis-market-access/payers-perspective-value-based-contracting-vbc/

Debates & Insights

Realising the biotech promise: addressing the path to market

Realising the biotech promise: addressing the path to market

Overview Now more than ever before, biotech is the engine for innovation in medicine, finding, creating and delivering

X

Realising the biotech promise: addressing the path to market

https://pharmaphorum.com/market-access-2/addressing-the-path-to-market/

Engaging with HCPS: what do HCPs want from medical meetings?

Engaging with HCPS: what do HCPs want from medical meetings?

There has been a myriad of reasons over the past few years to safely assume the popularity and

X

Engaging with HCPS: what do HCPs want from medical meetings?

https://pharmaphorum.com/webinars/webinars-on-demand/engaging-with-hcps-what-do-hcps-want-from-medical-meetings/

New report: Are clinical trials under threat from ‘system overload’?

New report: Are clinical trials under threat from ‘system overload’?

The 2017 Unified Clinical Operations Survey Report Nearly all (99%) of clinical operations professionals who responded to the

X

New report: Are clinical trials under threat from ‘system overload’?

https://pharmaphorum.com/debates-insight-market-access/new-report-clinical-trials-threat-system-overload/

Partner Content

An Interview with Alexander Zuern, Device Testing Manager, from Novartis

An Interview with Alexander Zuern, Device Testing Manager, from Novartis

Pre-Filled Syringes & Injectable Drug Devices Europe

X

An Interview with Alexander Zuern, Device Testing Manager, from Novartis

https://pharmaphorum.com/partner-content/an-interview-with-alexander-zuern-device-testing-manager-from-novartis/

SMi Presents the 13th Annual Conference: Parallel Trade 2019

SMi Presents the 13th Annual Conference: Parallel Trade 2019

parallel trade conference 2019

X

SMi Presents the 13th Annual Conference: Parallel Trade 2019

https://pharmaphorum.com/events/smi-presents-the-13th-annual-conference-parallel-trade-2019/

Update on Cold Chain Distribution 2018

Update on Cold Chain Distribution 2018

Cold Chain Distribution 2018

X

Update on Cold Chain Distribution 2018

https://pharmaphorum.com/partner-content/update-on-cold-chain-distribution-2018/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com